nanoNIPT: Short‐fragment nanopore sequencing of cell‐free DNA for non‐invasive prenatal testing of fetal aneuploidies and sex chromosome aberrations
Prenatal Diagnosis · 2023
DOI: 10.1002/pd.6331 ↗At a glance
Journal article in Prenatal Diagnosis, 2023. Written by Maria Winther Jørgensen and 2 co-authors. Institution: Department of Clinical Genetics, Odense University Hospital, Odense, Denmark. Major MEDLINE topics: Cell-Free Nucleic Acids, Nanopore Sequencing. Cited 9 times so far (Crossref); 7 references. The full text is freely available (open access, CC BY-NC 4.0). Funded by: Region Syddanmark Research Fund.
Abstract (original language)
Key points What's already known about this topic? Non‐invasive prenatal testing (NIPT) is a sensitive and risk‐free prenatal screening test for common aneuploidies. Until now, NIPT has required access to expensive next generation sequencing (NGS) sequencers, making it only accessible to large laboratories. What does this study add? This proof‐of‐concept study demonstrates that Oxford Nanopore platform, originally developed for long‐reads, can be used to sequence and analyze short cell‐free DNA (cfDNA) fragments with high efficiency and accuracy. We developed nanoNIPT for non‐invasive detection of fetal aneuploidies and sex chromosome aberrations, which enables NIPT testing without large upfront investments making it accessible in all the clinical labs around the world.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Department of Clinical Genetics, Odense University Hospital, Odense, Denmark.
- Human Genetics Unit, Department of Clinical Research, Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark.
ORCID profiles: Maria Winther Jørgensen, Ieva Miceikaitė, Martin J Larsen
Funding
- Region Syddanmark Research Fund
Cite
APA
Jørgensen, M. W., Miceikaitė, I., & Larsen, M. J. (2023). nanoNIPT: Short‐fragment nanopore sequencing of cell‐free DNA for non‐invasive prenatal testing of fetal aneuploidies and sex chromosome aberrations. Prenatal Diagnosis. https://doi.org/10.1002/pd.6331
Vancouver
Jørgensen MW, Miceikaitė I, Larsen MJ. nanoNIPT: Short‐fragment nanopore sequencing of cell‐free DNA for non‐invasive prenatal testing of fetal aneuploidies and sex chromosome aberrations. Prenatal Diagnosis. 2023. doi:10.1002/pd.6331
BibTeX
@article{Jrgensen2023,
author = {Jørgensen, Maria Winther and Miceikaitė, Ieva and Larsen, Martin J},
title = {nanoNIPT: Short‐fragment nanopore sequencing of cell‐free DNA for non‐invasive prenatal testing of fetal aneuploidies and sex chromosome aberrations},
journal = {Prenatal Diagnosis},
year = {2023},
doi = {10.1002/pd.6331}
}
EUVIMED